#South Korea #Seoul #K-Beauty #MEDIPEEL #Jason Wi

Jason Wi Takes Charge as CEO of MEDIPEEL

MEDIPEEL, a company majorly owned by Morgan Stanley Private Equity Asia, recently announced the appointment of Jason Wi as its new Chief Executive Officer. With the goal of steering the company towards improved global operational excellence and strategic growth, Wi is set to implement significant transformations within the organization.

A Vision for Transformation

Jason Wi has extensive experience in strategic consulting and investments, having previously worked with McKinsey & Company and SoftBank Ventures Asia. His career has demonstrated a strong ability to scale rapidly growing platform companies and facilitate international expansions for various businesses within the K-culture sector. With his expertise, MEDIPEEL aims to solidify its position as a leading player in the international beauty market.

As part of his comprehensive strategy, Wi is overseeing a restructuring of MEDIPEEL’s global operations to establish a robust and scalable operational model, designed to support sustained international growth. The company's shift from a traditional export-focused model to a more localized partnership approach aims to create a more organized and agile operational system, enabling them to maintain competitiveness across complex international markets.

Embracing Digital Innovation

Additionally, Jason Wi intends to integrate artificial intelligence and data-driven operational methodologies into MEDIPEEL’s core activities. This strategy is informed by his previous experiences in the platform industry, where he honed skills that will contribute to optimizing supply chain management and enhancing customer engagement, ultimately leading to improved long-term operational efficiency and revenue.

Wi emphasized that the sustainable success of K-beauty brands on the global stage relies on two main pillars: the brand’s heritage and a well-institutionalized operational system to uphold it. He expressed commitment to strengthening strategic global alliances while elevating internal standards to transform MEDIPEEL into a world-class, trusted beauty platform.

About MEDIPEEL

MEDIPEEL operates as a flagship of SKINIDEA, which belongs to MDP Holdings, a portfolio company under Morgan Stanley Private Equity Asia. SKINIDEA is renowned for its innovative products that blend premium ingredients with patented dermatological technology, catering to diverse skin types. Currently, the company exports to over 75 countries, investing in comprehensive research and clinical trials to develop highly effective cosmetic solutions that promise both immediate and long-lasting results.

In conclusion, with Jason Wi at the helm, MEDIPEEL is poised not only to adapt to shifting market conditions but also to thrive by leveraging its global resources and advanced strategies for operational excellence and strategic growth in the competitive landscape of the global beauty industry.